Literature DB >> 22134834

Radiation therapy in the prevention of brain metastases.

Joseph A Bovi1, Julia White.   

Abstract

Over 150,000 cancer patients will be diagnosed with brain metastases this year alone. Survival for those diagnosed with brain metastases remains poor despite multimodality management with surgery, chemotherapy, and radiation. Preventative strategies to mitigate brain metastases have met with mixed results. In leukemia and small cell lung cancer there are defined roles for preventative radiation to be delivered, which can result in improved local control and survival. There is a less defined role for preventative radiation in locally advanced non-small cell lung cancer and budding interest for radiation prevention in breast cancer. The potential impact preventative cranial irradiation may have on neurocognitive function and quality of life needs to be considered prior to its administration.

Entities:  

Mesh:

Year:  2012        PMID: 22134834     DOI: 10.1007/s11912-011-0208-6

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  64 in total

1.  Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.

Authors:  Hidefumi Aoyama; Masao Tago; Norio Kato; Tatsuya Toyoda; Masahiro Kenjyo; Saeko Hirota; Hiroki Shioura; Taisuke Inomata; Etsuo Kunieda; Kazushige Hayakawa; Keiichi Nakagawa; Gen Kobashi; Hiroki Shirato
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-08-01       Impact factor: 7.038

2.  Memory function before and after whole brain radiotherapy in patients with and without brain metastases.

Authors:  Grit Welzel; Katharina Fleckenstein; Jörg Schaefer; Brigitte Hermann; Uta Kraus-Tiefenbacher; Sabine K Mai; Frederik Wenz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-28       Impact factor: 7.038

3.  Curing children of leukemia.

Authors:  D Pinkel
Journal:  Cancer       Date:  1987-05-15       Impact factor: 6.860

4.  The central nervous system in childhood leukemia. I. The arachnoid.

Authors:  R A Price; W W Johnson
Journal:  Cancer       Date:  1973-03       Impact factor: 6.860

5.  Comparison of two methods of preventing central nervous system leukemia.

Authors:  R J Aur; H O Hustu; M S Verzosa; A Wood; J V Simone
Journal:  Blood       Date:  1973-09       Impact factor: 22.113

Review 6.  Cognitive effects of chemotherapy and/or cranial irradiation in adults.

Authors:  Grit Welzel; Sarah Steinvorth; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2005-03       Impact factor: 3.621

7.  Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

Authors:  Johanna C Bendell; Susan M Domchek; Harold J Burstein; Lyndsay Harris; Jerry Younger; Irene Kuter; Craig Bunnell; Montse Rue; Rebecca Gelman; Eric Winer
Journal:  Cancer       Date:  2003-06-15       Impact factor: 6.860

8.  Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC).

Authors:  R Komaki; C B Scott; R Byhardt; B Emami; S O Asbell; A H Russell; M Roach; M B Parliament; L E Gaspar
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-09-01       Impact factor: 7.038

9.  Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.

Authors:  Nancy U Lin; Véronique Diéras; Devchand Paul; Dominique Lossignol; Christos Christodoulou; Hans-Joachim Stemmler; Henri Roché; Minetta C Liu; Richard Greil; Eva Ciruelos; Sibylle Loibl; Stefania Gori; Andrew Wardley; Denise Yardley; Adam Brufsky; Joanne L Blum; Stephen D Rubin; Bernie Dharan; Klaudia Steplewski; Denise Zembryki; Cristina Oliva; Debasish Roychowdhury; Paolo Paoletti; Eric P Winer
Journal:  Clin Cancer Res       Date:  2009-02-15       Impact factor: 12.531

Review 10.  Current management and challenges of malignant disease in the CNS in paediatric leukaemia.

Authors:  Ching-Hon Pui; Scott C Howard
Journal:  Lancet Oncol       Date:  2008-03       Impact factor: 41.316

View more
  7 in total

1.  The Thr300Ala variant of ATG16L1 is associated with decreased risk of brain metastasis in patients with non-small cell lung cancer.

Authors:  Qian-Xia Li; Xiao Zhou; Ting-Ting Huang; Yang Tang; Bo Liu; Ping Peng; Li Sun; Yi-Hua Wang; Xiang-Lin Yuan
Journal:  Autophagy       Date:  2017-04-25       Impact factor: 16.016

2.  Extracellular superoxide dismutase is important for hippocampal neurogenesis and preservation of cognitive functions after irradiation.

Authors:  Yani Zou; Rikki Corniola; David Leu; Aslam Khan; Peyman Sahbaie; Ayanabha Chakraborti; David J Clark; John R Fike; Ting-Ting Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-10       Impact factor: 11.205

3.  Cognitive impairments following cranial irradiation can be mitigated by treatment with a tropomyosin receptor kinase B agonist.

Authors:  Phillip Yang; David Leu; Keqiang Ye; Chandra Srinivasan; John R Fike; Ting-Ting Huang
Journal:  Exp Neurol       Date:  2016-03-02       Impact factor: 5.330

4.  Computational Modeling of Micrometastatic Breast Cancer Radiation Dose Response.

Authors:  Daniel L Smith; Bisrat G Debeb; Howard D Thames; Wendy A Woodward
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-04-19       Impact factor: 7.038

5.  Prophylactic cranial irradiation reduces the incidence of brain metastasis in a mouse model of metastatic, HER2-positive breast cancer.

Authors:  Daniel L Smith; Bisrat G Debeb; Parmeswaran Diagaradjane; Richard Larson; Swaminathan Kumar; Jing Ning; Lara Lacerda; Li Li; Wendy A Woodward
Journal:  Genes Cancer       Date:  2021-03-13

6.  WDR5 is a prognostic biomarker of brain metastasis from non-small cell lung cancer.

Authors:  Zheng Li; Nan Liang; Na Wang; Yan Jia; Cui Tian
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

7.  SNPs in the TGF-β signaling pathway are associated with increased risk of brain metastasis in patients with non-small-cell lung cancer.

Authors:  Qianxia Li; Huanlei Wu; Bei Chen; Guangyuan Hu; Liu Huang; Kai Qin; Yu Chen; Xianglin Yuan; Zhongxing Liao
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.